ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Process Industries

Kaneka Corp.

Business Summary

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions Unit, Quality of Life Solutions Unit, Health Care Solutions Unit, Nutrition Solutions Unit and Others. The Material Solutions Unit segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility that includes weight reduction and fuel efficiency improvement. The Quality of Life Solutions Unit segment handles energy saving needs such as housing and living infrastructure, and development of internet of things (IoT) and artificial Intelligence (AI). The Health Care Solutions Unit segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicine. The Nutrition Solutions Unit segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2019 JPYUSD
Gross Profit169,419M1,527.74M
Operating income36,042M325.01M
Income before tax31,909M287.74M
Net income22,239M200.54M
Diluted EPS338.603.05
Dividends Per Share1000.90
Total Assets659,587M5,959.13M
Total liabilities298,859M2,700.08M
Total equity337,424M3,048.50M
Operating cash flow41,113M370.73M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 552,189M 555,227M 548,222M 596,142M 621,043M
Gross Profit 135,273M 156,955M 157,992M 163,939M 169,419M
Operating income 24,635M 38,220M 33,165M 36,252M 36,042M
Income before tax 28,174M 30,601M 28,692M 31,085M 31,909M
Net income 18,033M 20,985M 20,484M 21,572M 22,239M
EBITDA 48,885M 65,163M 61,492M 67,104M 68,646M
Diluted EPS 267.40 314.60 308.25 328.05 338.60
Dividends Per Share 80 90 90 90 100
Total Assets 557,962M 577,251M 592,900M 639,780M 659,587M
Total liabilities 248,735M 268,529M 271,346M 293,178M 298,859M
Total equity 298,398M 292,437M 305,421M 326,487M 337,424M
Operating cash flow 33,602M 59,704M 48,119M 49,750M 41,113M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 5,026.45M 4,623.64M 5,062.65M 5,378.76M 5,600.29M
Gross Profit 1,231.36M 1,307.04M 1,459.00M 1,479.16M 1,527.74M
Operating income 224.24M 318.27M 306.26M 327.08M 325.01M
Income before tax 256.46M 254.82M 264.96M 280.46M 287.74M
Net income 164.15M 174.75M 189.16M 194.63M 200.54M
EBITDA 444.98M 542.64M 567.85M 605.45M 619.01M
Diluted EPS 2.43 2.61 2.84 2.96 3.05
Dividends Per Share 0.72 0.74 0.83 0.81 0.90
Total Assets 4,652.59M 5,135.91M 5,320.82M 6,015.79M 5,959.13M
Total liabilities 2,074.08M 2,389.15M 2,435.12M 2,756.72M 2,700.08M
Total equity 2,488.20M 2,601.86M 2,740.92M 3,069.92M 3,048.50M
Operating cash flow 305.87M 497.18M 444.36M 448.87M 370.73M

Valuation Measures

Mar 2019
Operating margin5.80%
Profit margin3.58%

Key executives

  • President & Representative Director: Mamoru Kadokura
  • Director, Head-Investor & Public Relations: Shinobu Ishihara
  • Representative Director & Vice President: Minoru Tanaka
  • Director & Managing Executive Officer: Hidesuke Amachi
  • Director & Managing Executive Officer: Akira Iwazawa


  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (5.9%)
  • Nippon Life Insurance Co. (4.5%)
  • Sumitomo Mitsui Financial Group, Inc. (4.5%)
  • Mitsubishi UFJ Financial Group, Inc. (4.2%)
  • Meiji Yasuda Life Insurance Co. (4.1%)
  • Kaneka Corp. (4.0%)
  • Eastspring Investments (Singapore) Ltd. (3.3%)
  • MS&AD Insurance Group Holdings, Inc. (3.0%)
  • BlackRock Fund Advisors (2.8%)
  • The Vanguard Group, Inc. (2.2%)

Contact Details

  • Website:
  • Address: Nakanoshima Festival Tower, 35/F, 2-3-18 Nakanoshima, Osaka, 530-8288, Japan
  • Phone: +81.6.6266.5050

Related Companies

  • Kaneka Pension Fund
  • Kaneka Employee Incentive Plan
  • Kaneka Europe Holding Company NV
  • Kaneka Pharma Vietnam Co. Ltd.
  • Kaneka Taiwan Corp.
  • Kaneka India Pvt Ltd.
  • Kaneka Apical Malaysia Sdn. Bhd.
  • Kaneka (Foshan) Chemical Industries Co. Ltd.
  • Kaneka South America Representative Ltd.
  • PT Kaneka Foods Indonesia
  • Kaneka Korea Corp.
  • Kaneka Singapore Co. (Pte) Ltd.
  • HiHua Fiber Co. Ltd.
  • Kaneka Innovative Fibers Sdn. Bhd.
  • Kaneka Eperan (Suzhou) Co. Ltd.
  • Kaneka Trading (Shanghai) Co. Ltd.
  • River Co., Ltd. (Japan)
  • Kaneka Americas Holding, Inc.
  • GeneFrontier Corp.
  • Tohoku Device Co. Ltd. /Organic El Lighting Device Ops/
  • Kaneka Business Association
  • Kaneka Medix Corp.
  • Hokkaido Kaneka Co. Ltd.
  • Showa Kasei Kogyo Co. Ltd.
  • Kaneka Techno Research Co. Ltd.
  • Kaneka Engineering Corp.
  • Tokai Kaneka Shokuhin Co. Ltd.
  • Tochigi Kaneka Corp.
  • Tatsuta Chemical Co. Ltd.
  • Kaneka Solartech Corp.


  • Westlake Chemical Corporation
  • Innophos Holdings, Inc.
  • Orbia Advance Corp. SAB de CV
  • Shandong Ruifeng Chemical Co., Ltd. Class A
  • CytoSorbents Corporation
Last Updated on 18 Nov, 2019

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media